KPTI Karyopharm Therapeutics Inc.
Nasdaq · SEC CIK 1503802 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $351.6K 20 sales by 7 insiders
- Filings on record
- 204 since 2021-07-01, latest 2026-09-02 16:57
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Paulson Richard A. | Pres, CEO, Dir | — | $137.2K |
| Poulton Stuart | EVP, Chief Development Off | — | $56.4K |
| Rangwala Reshma | EVP, Chief Medical Off | — | $55.6K |
| Cheng Sohanya Roshan | EVP, Chief Commercial Off | — | $46.4K |
| Mano Michael | SVP, GC, Sec | — | $35.7K |
| Macomber Lori | EVP, CFO, Treas | — | $10.2K |
| Abate Kristin | CAO | — | $10.0K |
| Su Zhen | Dir | — | — |
| Oliger Christy J. | Dir | — | — |
| Schor Chen | Dir | — | — |
Transactions 203
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-03 | 2021-12-02 | KPTI | Mitchener Stephen | SVP, Chief Business Off | S - Sale | $6.69 | -499 | 3,296 | -13% | -$3,338 | |
| 2021-07-13 | 2021-07-12 | KPTI | Shah Jatin | EVP, Chief Medical Off | F - Tax | $9.73 | -665 | 131.1K | -0.5% | -$6,470 | |
| D | 2021-07-01 | 2021-06-30 | KPTI | Cheng Sohanya Roshan | SVP Sales, Commercial Ops | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations